Related content

Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer

By Mori Kiyoshi   Kamiyama Yukari   Kondo Tetsuro   Kano Yasuhiko   Tominaga Keigo  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 129-132

Springer Publishing Company

Access to resources Recommend Favorite

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

By Frasci Giuseppe   Comella Pasquale   Thomas Renato   Bonito Maurizio   Lapenta Liliana   Capasso Immacolata   Botti Gerardo   Vallone Paolo   Rosa Vincenzo   D'Aiuto Giuseppe   Comella Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 25-32

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer

By                    

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 167-170

Spandidos Publications

Access to resources Recommend Favorite

Combination of Cisplatin and Interferon- 2a (Roferon(R)-A) in Patients with Non-small Cell Lung Cancer (NSCLC). An Open Phase II Multicentre Study

By Kataja V.   Yap A.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

Combination of cisplatin and interferon alfa-2a (Roferon-A) in patients with non small cell lung cancer (NSCLC). An open phase II multicentre study

By  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1028-1028

Elsevier

Access to resources Recommend Favorite